Pulmonx Corporation (NASDAQ: LUNG) reported Q3 EPS of ($0.39), $0.04 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $17.7 million versus the consensus estimate of $16.39 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.